Henry Schein EBITDA 2010-2024 | HSIC

Henry Schein annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Henry Schein EBITDA for the quarter ending March 31, 2024 was $0.223B, a 1.76% decline year-over-year.
  • Henry Schein EBITDA for the twelve months ending March 31, 2024 was $886M, a 0.11% decline year-over-year.
  • Henry Schein 2023 annual EBITDA was $0.89B, a 7.19% decline from 2022.
  • Henry Schein 2022 annual EBITDA was $0.959B, a 9.7% decline from 2021.
  • Henry Schein 2021 annual EBITDA was $1.062B, a 47.3% increase from 2020.
Henry Schein Annual EBITDA
(Millions of US $)
2023 $890
2022 $959
2021 $1,062
2020 $721
2019 $903
2018 $744
2017 $804
2016 $941
2015 $893
2014 $867
2013 $811
2012 $744
2011 $698
2010 $626
2009 $552
Henry Schein Quarterly EBITDA
(Millions of US $)
2024-03-31 $223
2023-12-31 $134
2023-09-30 $269
2023-06-30 $260
2023-03-31 $227
2022-12-31 $124
2022-09-30 $263
2022-06-30 $273
2022-03-31 $299
2021-12-31 $260
2021-09-30 $263
2021-06-30 $260
2021-03-31 $279
2020-12-31 $228
2020-09-30 $232
2020-06-30 $40
2020-03-31 $221
2019-12-31 $245
2019-09-30 $234
2019-06-30 $211
2019-03-31 $213
2018-12-31 $195
2018-09-30 $159
2018-06-30 $193
2018-03-31 $198
2017-12-31 $44
2017-09-30 $262
2017-06-30 $258
2017-03-31 $239
2016-12-31 $258
2016-09-30 $243
2016-06-30 $223
2016-03-31 $217
2015-12-31 $241
2015-09-30 $232
2015-06-30 $222
2015-03-31 $199
2014-12-31 $243
2014-09-30 $213
2014-06-30 $218
2014-03-31 $193
2013-12-31 $219
2013-09-30 $192
2013-06-30 $208
2013-03-31 $192
2012-12-31 $215
2012-09-30 $180
2012-06-30 $186
2012-03-31 $164
2011-12-31 $193
2011-09-30 $172
2011-06-30 $180
2011-03-31 $153
2010-12-31 $168
2010-09-30 $163
2010-06-30 $165
2010-03-31 $130
2009-12-31 $160
2009-09-30 $136
2009-06-30 $144
2009-03-31 $112
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $9.120B $12.339B
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.631B 21.23
Becton Dickinson (BDX) United States $67.642B 19.14
West Pharmaceutical Services (WST) United States $23.823B 42.69
Cardinal Health (CAH) United States $23.375B 13.37
Align Technology (ALGN) United States $18.864B 36.42
Labcorp (LH) United States $18.190B 15.66
Cooper (COO) United States $18.112B 26.71
DENTSPLY SIRONA (XRAY) United States $5.718B 14.81
Merit Medical Systems (MMSI) United States $5.034B 27.59
Patterson (PDCO) United States $2.315B 11.42
CONMED (CNMD) United States $2.267B 20.56
STAAR Surgical (STAA) United States $2.173B 83.45
Atrion (ATRI) United States $0.803B 42.90
Lifevantage (LFVN) United States $0.081B 10.51
Pro-Dex (PDEX) United States $0.068B 34.31